Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
出版年份 2019 全文链接
标题
Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
作者
关键词
-
出版物
CNS DRUGS
Volume 33, Issue 9, Pages 905-918
出版商
Springer Science and Business Media LLC
发表日期
2019-08-31
DOI
10.1007/s40263-019-00661-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Continuous subcutaneous apomorphine in advanced Parkinson’s disease patients treated with deep brain stimulation
- (2019) Ángel Sesar et al. JOURNAL OF NEUROLOGY
- Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone
- (2019) Kıvanç Yüksel et al. International Journal of Clinical Pharmacy
- Pharmacological Insights into the Use of Apomorphine in Parkinson’s Disease: Clinical Relevance
- (2018) Manon Auffret et al. CLINICAL DRUG INVESTIGATION
- ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative Bioavailability
- (2018) Yuval Ramot et al. CNS DRUGS
- Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease
- (2018) Angelo Antonini et al. JOURNAL OF NEURAL TRANSMISSION
- Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF-episodes in subjects with Parkinson’s disease: preliminary results from the Phase-3 study dose titration phase
- (2018) H.H. Fernandez et al. PARKINSONISM & RELATED DISORDERS
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
- (2018) Regina Katzenschlager et al. LANCET NEUROLOGY
- Apomorphine infusion in advanced Parkinson disease
- (2018) Angelo Antonini et al. Nature Reviews Neurology
- Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study
- (2017) Thomas E. Kimber et al. INTERNAL MEDICINE JOURNAL
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- Continuous subcutaneous apomorphine infusion in advanced Parkinson’s disease: 10-year experience with 230 patients
- (2017) Ángel Sesar et al. JOURNAL OF NEUROLOGY
- Efficacy of oral lipid-based formulations of apomorphine and its diester in a Parkinson's disease rat model
- (2017) Nrupa Borkar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study
- (2017) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease
- (2016) Christel Renoux et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study
- (2016) Sophie Drapier et al. JOURNAL OF NEUROLOGY
- Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease
- (2016) Robert A. Hauser et al. MOVEMENT DISORDERS
- Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence
- (2016) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- The efficacy of apomorphine – A non-motor perspective
- (2016) Miguel Rosa-Grilo et al. PARKINSONISM & RELATED DISORDERS
- Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors
- (2016) Roongroj Bhidayasiri et al. PARKINSONISM & RELATED DISORDERS
- Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients
- (2016) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- Apomorphine - pharmacological properties and clinical trials in Parkinson's disease
- (2016) Peter Jenner et al. PARKINSONISM & RELATED DISORDERS
- Effective Delivery of Apomorphine in the Management of Parkinson Disease
- (2015) Roongroj Bhidayasiri et al. CLINICAL NEUROPHARMACOLOGY
- A Randomized Controlled Trial of Subcutaneous Apomorphine for Parkinson Disease
- (2015) Masahiro Nomoto et al. CLINICAL NEUROPHARMACOLOGY
- Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?
- (2015) Alison J. Yarnall et al. MOVEMENT DISORDERS
- Management of impulse control disorders in Parkinson's disease: Controversies and future approaches
- (2015) Michael Samuel et al. MOVEMENT DISORDERS
- Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations
- (2015) Claudia Trenkwalder et al. PARKINSONISM & RELATED DISORDERS
- Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence fromIn VivoCanine Models
- (2014) Yudai Watanabe et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Sustained efficacy of apomorphine in Japanese patients with advanced Parkinson's disease
- (2014) Nobutaka Hattori et al. PARKINSONISM & RELATED DISORDERS
- Le traitement par apomorphine en perfusion continue sous-cutanée dans la maladie de Parkinson : analyse rétrospective d’une série de 81 patients
- (2014) M. Rambour et al. REVUE NEUROLOGIQUE
- Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
- (2014) Thomas J. Moore et al. JAMA Internal Medicine
- Inhaled dry powder apomorphine (VR040) for ‘off ’ periods in Parkinson's disease: an in-clinic double-blind dose ranging study
- (2013) K. A. Grosset et al. ACTA NEUROLOGICA SCANDINAVICA
- Erich Harnack (1852–1915) and a Short History of Apomorphine
- (2013) Pille Taba et al. EUROPEAN NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Apomorphine infusion in advanced Parkinson’s patients with subthalamic stimulation contraindications
- (2011) Sophie Drapier et al. PARKINSONISM & RELATED DISORDERS
- Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation
- (2010) Eri Himeno et al. ANNALS OF NEUROLOGY
- Effect of Low Concentrations of Apomorphine on Parkinsonism in a Randomized, Placebo-Controlled, Crossover Study
- (2008) Steven A. Gunzler et al. ARCHIVES OF NEUROLOGY
- Open-Label Study Assessment of Safety and Adverse Effects of Subcutaneous Apomorphine Injections in Treating "Off" Episodes in Advanced Parkinson Disease
- (2008) Peter A. LeWitt et al. CLINICAL NEUROPHARMACOLOGY
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now